99.28
-1.57(-1.56%)
Currency In USD
| Previous Close | 100.85 |
| Open | 100.19 |
| Day High | 103.53 |
| Day Low | 99.24 |
| 52-Week High | 126.89 |
| 52-Week Low | 56.44 |
| Volume | 551,183 |
| Average Volume | 933,337 |
| Market Cap | 6.8B |
| PE | 22.77 |
| EPS | 4.36 |
| Moving Average 50 Days | 91.76 |
| Moving Average 200 Days | 96.06 |
| Change | -1.57 |
If you invested $1000 in Lantheus Holdings, Inc. (LNTH) since IPO date, it would be worth $14,664.7 as of March 13, 2025 at a share price of $99.28. Whereas If you bought $1000 worth of Lantheus Holdings, Inc. (LNTH) shares 5 years ago, it would be worth $7,684.21 as of March 13, 2025 at a share price of $99.28.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Lantheus to Present at Upcoming Investor Conferences
GlobeNewswire Inc.
Feb 21, 2025 1:30 PM GMT
BEDFORD, Mass., Feb. 21, 2025 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver better patient outc
Lantheus to Host Fourth Quarter and Full Year 2024 Earnings Conference Call and Webcast on February 26, 2025, at 8:00 a.m. Eastern Time
GlobeNewswire Inc.
Feb 12, 2025 1:00 PM GMT
BEDFORD, Mass., Feb. 12, 2025 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH) today announced that it will host a conference call and webcast at 8:00 a.m. ET on Wednesday, February 26, 2025, to discuss its financial and o
Lantheus Announces Presentations Featuring PYLARIFY (Piflufolastat F 18) Data at the ASCO GU Meeting
GlobeNewswire Inc.
Feb 05, 2025 1:30 PM GMT
Data highlights PYLARIFY’s ability to detect recurrent prostate cancer in patients with low PSA Real-world evidence of PYLARIFY’s effectiveness in prostate cancer being presented BEDFORD, Mass., Feb. 05, 2025 (GLOBE NEWSWIRE) -- Lantheus Holdings,